2020 Health Insurance Medicare Patient Advocacy 
C&M Health Law
NOVEMBER 7, 2022
The EO comes two months after the president signed the Inflation Reduction Act (IRA) which promises to lower the cost of prescription drugs for many Medicare beneficiaries. This is not the first time that the White House will try to leverage CMMI’s testing authority to create models that would lower drug costs in Medicare.
Health Populi
OCTOBER 8, 2019
More savings would accrue through the quicker adoption of value-based payment models, the authors assert, where clinicians take on financial risk for managing population health. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027.
Expert insights. Personalized for you.
52 
Let's personalize your content